as on January 14, 2026 at 2:29 am IST
Day's Low
Day's High
2.41%
Downside
2.81%
Upside
52 Week's Low
52 Week's High
46.07%
Downside
20.65%
Upside
Check Mesoblast market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.9B
EPS (TTM)
-0.2767
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-58.2M
Revenue (TTM)
17.2M
Profit Margin
0.00%
Return On Equity TTM
-18.95%
Compare market cap, revenue, PE, and other key metrics of Mesoblast with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.9B | -9.66% | NA | 0.00% | |
| BUY | $49.0B | 124.12% | 1236.37 | 1.36% | |
| BUY | $118.1B | 101.07% | 32.37 | 31.35% | |
| NA | $37.0B | NA | 630.17 | 1.38% | |
| BUY | $81.4B | 46.53% | 18.42 | 32.13% |
The Mesoblast stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Mesoblast investment value today
Current value as on today
₹1,09,020
Returns
₹9,020
(+9.02%)
Returns from Mesoblast Stock
₹4,947 (+4.95%)
Dollar Returns*
₹4,073 (+4.07%)
Based on 9 analysts
77.78%
Buy
22.22%
Hold
0.00%
Sell
Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Mesoblast. Average target price of $35
Get share price movements and forecasts by analysts on Mesoblast.
What analysts predicted
49.09%UPSIDE
Target Price
$35
Current Price
$17.82
Analyzed by
9 Analysts
Target
$35.00
Mesoblast target price $35, a slight upside of 49.09% compared to current price of $17.82. According to 9 analysts rating.
Search interest for Mesoblast Stock has increased by 313% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:313% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 5 quarters, 1.25M → 7.02M (in $), with an average increase of 24.5% per quarter
Best in 3 Years
![]()
In the last 3 years, MESO has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 74.7% return, outperforming this stock by 70.1%
Price Dip
![]()
In the last 7 days, MESO stock has moved down by -7.8%
Profit Down
![]()
Netprofit is down for the last 3 quarters, -23.96M → -27.10M (in $), with an average decrease of 6.5% per quarter
| Organisation | Mesoblast |
| Headquarters | 55 Collins Street, Melbourne, VIC, Australia, 3000 |
| Industry | Health Technology |
| CEO | Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons) |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Geraldine Storton B.Sc., M.B.A., MMS | Head of Regulatory Affairs & Quality Management |
Dr. Fiona See Ph.D. | Senior VP & Head of Translational Research |
Ms. Niva Sivakumar B.Com., L.L.B. | Joint Company Secretary |
Dr. Paul J. Simmons BSc, Ph.D. | Scientific Advisor to the Chief Executive Officer |
Dr. Eric A. Rose M.D. | Chief Medical Officer & Executive Director |
Mr. James Michael O'Brien | Chief Financial Officer |
Mr. Peter T. Howard B.Sc., L.L.B. | General Counsel & Corporate Executive |
Mr. Justin Horst B.S. | Head of Manufacturing |
Mr. Marcelo Santoro | Chief Commercial Officer |
Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons) | Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director |
Mesoblast share price today is $17.82 as on at the close of the market. Mesoblast share today touched a day high of $18.32 and a low of $17.39.
Mesoblast share touched a 52 week high of $21.5 on and a 52 week low of $9.61 on . Mesoblast stock price today i.e. is closed at $17.82,which is 17.12% down from its 52 week high and 85.43% up from its 52 week low.
Mesoblast market capitalisation is $0.00T as on .
Indian investors can start investing in Mesoblast (MESO) shares with as little as ₹90.18 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹901.80 in Mesoblast stock (as per the Rupee-Dollar exchange rate as on ).
Based on Mesoblast share’s latest price of $17.82 as on January 14, 2026 at 2:29 am IST, you will get 0.5612 shares of Mesoblast. Learn more about
fractional shares .
Mesoblast stock has given -9.66% share price returns and 23.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?